- Home
- NHS vs INGN Comparison
NHS vs INGN Comparison
Compare NHS & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NHS
- INGN
- Stock Information
- Founded
- NHS 2003
- INGN 2001
- Country
- NHS United States
- INGN United States
- Employees
- NHS N/A
- INGN N/A
- Industry
- NHS Trusts Except Educational Religious and Charitable
- INGN Industrial Specialties
- Sector
- NHS Finance
- INGN Health Care
- Exchange
- NHS Nasdaq
- INGN Nasdaq
- Market Cap
- NHS 213.4M
- INGN 222.0M
- IPO Year
- NHS N/A
- INGN 2014
- Fundamental
- Price
- NHS $7.65
- INGN $9.46
- Analyst Decision
- NHS
- INGN Hold
- Analyst Count
- NHS 0
- INGN 3
- Target Price
- NHS N/A
- INGN $7.00
- AVG Volume (30 Days)
- NHS 111.8K
- INGN 226.5K
- Earning Date
- NHS 01-01-0001
- INGN 11-07-2024
- Dividend Yield
- NHS 13.44%
- INGN N/A
- EPS Growth
- NHS N/A
- INGN N/A
- EPS
- NHS N/A
- INGN N/A
- Revenue
- NHS N/A
- INGN $331,520,000.00
- Revenue This Year
- NHS N/A
- INGN $6.09
- Revenue Next Year
- NHS N/A
- INGN $4.17
- P/E Ratio
- NHS N/A
- INGN N/A
- Revenue Growth
- NHS N/A
- INGN 1.12
- 52 Week Low
- NHS $6.95
- INGN $4.93
- 52 Week High
- NHS $9.17
- INGN $13.33
- Technical
- Relative Strength Index (RSI)
- NHS 27.55
- INGN 46.09
- Support Level
- NHS $7.96
- INGN $9.24
- Resistance Level
- NHS $8.16
- INGN $10.22
- Average True Range (ATR)
- NHS 0.13
- INGN 0.50
- MACD
- NHS -0.04
- INGN -0.02
- Stochastic Oscillator
- NHS 0.94
- INGN 27.24
About NHS Neuberger Berman High Yield Strategies Fund
Neuberger Berman High Yield Strategies Fund is closed-end management investment company. It seeks to achieve its investment objective by investing, under normal market conditions, a majority of its total assets in high yield debt securities of U.S. and foreign issuers.
About INGN Inogen Inc
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.